| Absorption |
| Blood-Brain Barrier | BBB- | 0.6415 |
| Human Intestinal Absorption | HIA+ | 0.9949 |
| Caco-2 Permeability | Caco2+ | 0.7597 |
| P-glycoprotein Substrate | Non-substrate | 0.6466 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9179 |
| Non-inhibitor | 0.9510 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9083 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8836 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7869 |
| CYP450 2D6 Substrate | Non-substrate | 0.9017 |
| CYP450 3A4 Substrate | Non-substrate | 0.6952 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5672 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.7094 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9518 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6209 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9245 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.6466 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9726 |
| Non-inhibitor | 0.7636 |
| AMES Toxicity | Non AMES toxic | 0.7577 |
| Carcinogens | Non-carcinogens | 0.8471 |
| Fish Toxicity | High FHMT | 0.9721 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9885 |
| Honey Bee Toxicity | High HBT | 0.6254 |
| Biodegradation | Not ready biodegradable | 0.8679 |
| Acute Oral Toxicity | III | 0.7001 |
| Carcinogenicity (Three-class) | Warning | 0.5331 |